Legance, Linklaters, King & Spalding, EY SLT and Machado, Meyer, Sendacz e Opice advised Almaviva, while Latham & Watkins advised Iteris. PedersoliGattai, Milbank and TozziniFreire advised...
You must be a Standard 1 Year member to access this content.
Latham & Watkins acted for Iteris; King & Spalding, Legance and Linklaters advised Almaviva. The Italian group Almaviva S.p.A. has acquired Iteris, a company listed on...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advises Revolution Medicines on the deal, and Goodwin Procter advises EQRx. Revolution Medicines, Inc. (Nasdaq: RVMD) and EQRx, Inc. (Nasdaq: EQRX) announced a definitive agreement...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Cadence, and Wilson Sonsini Goodrich & Rosati advised Rambus on the transaction. Cadence Design Systems, Inc. and Rambus Inc. announced that they have entered...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised dbt Labs on the deal. dbt Labs announced that it has signed a definitive agreement to acquire Transform Data Inc. The acquisition...
You must be a Standard 1 Year member to access this content.
